Fight CRC Clinical Trial Finder
| NCT ID | Title | 阶段 | Date Added | 地点 | Prior IO Allowed | CRC-directed | Status | 药物 | 标签 |
|---|---|---|---|---|---|---|---|---|---|
| NCT ID NCT04708470 |
TitlePhase I/II Trial of the Combination of Bintrafusp Alfa (M7824), Entinostat and NHS-IL12 (M9241) in Patients With Advanced Cancer | 阶段
Phase 1, Phase 2
|
Date Added 2021-01-14 |
地点
Maryland, United States
|
Prior IO Allowed 没有 |
CRC-directed 是 |
Status
活跃，非招募
|
药物
Bintrafusp alfa, Entinostat, NHS-IL12 |
标签
MSS/ MMRp
|
| NCT ID NCT04362839 |
TitleRegorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer | 阶段
第 1 阶段
|
Date Added 2020-04-27 |
地点
California, United States
|
Prior IO Allowed 没有 |
CRC-directed 是 |
Status
活跃，非招募
|
药物
Ipilimumab, Nivolumab, Regorafenib, Opdivo, Stivarga, Yervoy |
标签
MSS/ MMRp
|
| NCT ID NCT04092673 |
TitleeFT226 对部分晚期实体瘤恶性肿瘤受试者的研究 | 阶段
第 1 阶段
|
Date Added 2019-09-17 |
地点
California, United States
Michigan, United States Nevada, United States New Jersey, United States New York, United States Ohio, United States Texas, United States Virginia, United States |
Prior IO Allowed 没有 |
CRC-directed 没有 |
Status
招聘
|
药物
eFT226, eFT226 |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT03796884 |
TitleLinaclotide in Treating Patients With Stages 0-3 Colorectal Cancer | 阶段
第二阶段
|
Date Added 2019-01-08 |
地点
Pennsylvania, United States
Washington, United States |
Prior IO Allowed 没有 |
CRC-directed 是 |
Status
活跃，非招募
|
药物
Linaclotide |
标签
MSS/ MMRp
|
| NCT ID NCT02864485 |
Title活体肝移植治疗无法切除的结直肠癌肝转移灶 | 阶段
不适用
|
Date Added 2016-08-12 |
地点
加拿大
|
Prior IO Allowed 没有 |
CRC-directed 是 |
Status
招聘
|
药物 |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT04050709 |
TitleQUILT 3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers | 阶段
第 1 阶段
|
Date Added 2019-08-08 |
地点
California, United States
|
Prior IO Allowed 没有 |
CRC-directed 没有 |
Status
活跃，非招募
|
药物
PD-L1 t-haNK |
标签
MSS/ MMRp
|
| NCT ID NCT02675946 |
TitleCGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596) | 阶段
第 1 阶段
|
Date Added 2016-02-05 |
地点
California, United States
Colorado, United States Connecticut, United States District of Columbia, United States Florida, United States Georgia, United States Hawaii, United States Illinois, United States Indiana, United States Maryland, United States Massachusetts, United States Nebraska, United States New Jersey, United States North Carolina, United States Pennsylvania, United States South Dakota, United States Tennessee, United States Texas, United States Washington, United States Wisconsin, United States 台湾 |
Prior IO Allowed 没有 |
CRC-directed 没有 |
Status
招聘
|
药物
cetuximab, CGX1321, encorafenib, Pembrolizumab, Keytruda |
标签
MSS/ MMRp
|
| NCT ID NCT03608046 |
TitleAvelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer | 阶段
第二阶段
|
Date Added 2018-07-31 |
地点
比利时
|
Prior IO Allowed 没有 |
CRC-directed 是 |
Status
招聘
|
药物
Avelumab, Cetuximab Injection, Irinotecan |
标签
MSS/ MMRp
|
| NCT ID NCT03626922 |
TitleStudy of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients | 阶段
第 1 阶段
|
Date Added 2018-08-13 |
地点
Florida, United States
Illinois, United States Michigan, United States Minnesota, United States Pennsylvania, United States |
Prior IO Allowed 没有 |
CRC-directed 是 |
Status
活跃，非招募
|
药物
Dexamethasone, oxaliplatin, Pembrolizumab, Pemetrexed, Alimta, Eloxatin, Keytruda |
标签
MSS/ MMRp
|
| NCT ID NCT03013218 |
TitleA Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01) | 阶段
第 1 阶段
|
Date Added 2017-01-06 |
地点
Colorado, United States
Connecticut, United States Massachusetts, United States Michigan, United States Washington, United States 大韩民国 |
Prior IO Allowed 没有 |
CRC-directed 没有 |
Status
活跃，非招募
|
药物
5-FU + Cisplatin, Evorpacept (ALX148), Pembrolizumab, Ramucirumab + Paclitaxel, Rituximab, Trastuzumab |
标签
MSS/ MMRp
|
